申请人:SCHERING CORPORATION
公开号:EP0347698A1
公开(公告)日:1989-12-27
Heterobicyclic and heterocyclic intermediate compounds and their use in treating inflammation, hyperproliferative skin conditions such as psoriasis and allergy are disclosed.
本研究公开了杂双环和杂环中间体化合物及其在治疗炎症、过度增生性皮肤病(如牛皮癣)和过敏症中的用途。